miR-19b 通过 JAK/STAT 通路上游机制抑制小鼠过敏性结膜炎眼部炎症的潜在作用
该研究在小鼠过敏性结膜炎模型中观察 miR-19b 的表达、调控与功能。结果显示 miR-19b 异常下调,TSLP、p-STAT3 及 CD11c+ pSTAT3+ 树突状细胞增多,Th2 炎症因子表达升高;外源性 miR-19b mimic 或 JAK/STAT 抑制剂 CYT387 可逆转上述严重表型。结论提示 miR-19b 通过下调 TSLP 抑制 Stat3 信号,减轻眼表炎症,具有临床潜力。
要点
- 小鼠过敏性结膜炎模型中 miR-19b 表达异常下调。
- 外源性 miR-19b mimic 或 JAK/STAT 抑制剂 CYT387 可逆转炎症表型。
- miR-19b 通过下调 TSLP 抑制 Stat3 信号减轻眼表炎症。
核心结论
- 在小鼠过敏性结膜炎模型中,miR-19b 通过下调 TSLP 抑制 Stat3 信号,从而减轻眼表炎症。
- 研究提示应用 miR-19b 及抗 JAK/STAT 疗法治疗过敏性结膜炎具有临床潜力。
研究设计与样本
- 采用 BALB/c 小鼠以短豚草花粉诱导实验性过敏性结膜炎模型。
- 研究使用血清、眼球、结膜和颈部淋巴结组织。
- 基因表达用 RT-PCR 检测,蛋白产生与活化用免疫染色、ELISA 和 Western blotting 评估。
主要发现
- 小鼠过敏性结膜炎模型中 miR-19b 异常下调。
- 模型中 TSLP 和 p-STAT3 水平升高,CD11c+ pSTAT3+ 树突状细胞数量增加。
- Th2 炎症细胞因子表达显著增加。
- 应用外源性 miR-19b mimic microRNA 或 JAK/STAT 抑制剂 CYT387 可抵消上述严重表型。
- 过表达 miR-19b 抑制过敏性结膜炎眼和颈部淋巴结组织中 p-STAT3 表达及 CD11c+ 细胞数量。
临床怎么用
- 本研究为动物实验,提示 miR-19b 和抗 JAK/STAT 疗法可能成为过敏性结膜炎的治疗方向,尚需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Thymic stromal lymphopoietin (TSLP) is a pro-allergic cytokine that initiates allergic inflammatory reaction between epithelial and dendritic cells (DCs). miR-19b was reported to suppress TSLP expression. The present study aimed to examine miR-19b expression, regulation, and function in allergic conjunctivitis (AC). METHODS: A murine model of experimental AC was induced in BALB/c mice by short ragweed pollen. The serum, eye balls, conjunctiva, and cervical lymph nodes (CLN) were used for the study. Gene expression was determined by RT-PCR, whereas protein production and activation were evaluated by immunostaining, ELISA, and Western blotting. RESULTS: In the murine AC model, miR-19b was aberrantly downregulated, whereas the levels of TSLP and p-STAT3, as well as the number of CD11c+ pSTAT3+ DCs were increased. Moreover, Th2 inflammatory cytokine expression was significantly increased. These severe phenotypes could be counteracted by either applying exogenous miR-19b mimic microRNAs or the JAK/STAT inhibitor CYT387. Moreover, overexpression of miR-19b repressed p-STAT3 expression and the number of CD11c+ cells in AC eye and CLN tissues. CONCLUSIONS: These findings suggested that miR-19b reduced ocular surface inflammation by inhibiting Stat3 signaling via TSLP downregulation in a murine AC model. Moreover, the present study further demonstrated the clinical potential of applying miR-19b and anti-JAK/STAT therapies in the treatment of AC.
引用
- Guo C, Liu J, Hao P, et al. The Potential Inhibitory Effects of miR-19b on Ocular Inflammation are Mediated Upstream of the JAK/STAT Pathway in a Murine Model of Allergic Conjunctivitis. Invest Ophthalmol Vis Sci. 2020. PMID: 32150250. doi:10.1167/iovs.61.3.8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。